GETTING THE RIGHT TREATMENT FOR YOUR KNEE OA

There are simple treatment options available for symptoms of knee OA. Among the most commonly used medications are NonSteroidal Anti-Inflammatory Drugs, or NSAIDs.

  • NSAIDs are a class of medicines that treat the pain and inflammation of some medical conditions

YOU HAVE A CHOICE IN TREATMENT.

Some NSAIDs are taken orally and others are applied topically.

  • Oral medications are generally released in the stomach and then go into your bloodstream
  • As a result, a larger amount of the medicine goes through your whole body than it would with a topical medicine.
  • A topical medication is applied to the skin
  • Topical treatments allow you to apply the medication directly to your knee

All NSAIDs, including oral, topical, and even nonprescription versions, such as ibuprofen, or naproxen,
pose serious risk of cardiovascular and gastrointestinal side effects.

  • Studies suggest that topical NSAIDs may offer safety benefits for the stomach and intestines compared to oral NSAIDs in some patients

Localized Treatment for Knee OA

ASK YOUR DOCTOR IF PENNSAID® TOPICAL NSAID SOLUTION IS RIGHT FOR YOU.

Tell your doctor about all of your symptoms and if your knee OA pain interferes with everyday activities. Only you and your doctor can decide if PENNSAID is right for you.

Altman RD. Practical considerations for the pharmacologic management of osteoarthritis. Am J Manag Care. 2009;15:S236-S243. Arthritis Foundation. All about Osteoarthritis. http://www.arthritistoday.org. Accessed January 6, 2011. Arthritis Foundation. NSAIDs. Arthritis Today Drug Guide. http://www.arthritistoday.org/treatments/drug‑guide/types‑of‑drugs/drug‑guide‑nsaids.php. Accessed January 6, 2011. Arthritis Foundation. NSAIDs. Who gets osteoarthritis. http://www.arthritis.org/who‑gets‑osteoarthritis.php. Accessed January 6, 2011. Arthrotec (diclofenac sodium/misoprostol) Tablets USP [prescribing information]. New York, NY: G.D. Searle LLC, Division of Pfizer. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833-1840. Diclofenac sodium delayed release tablets USP [prescribing information]. Corona, CA: Watson Laboratories, Inc. Evans JMM, McMahon AD, McGilchrist MM, et al. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. Br Med J. 1995;311:22-26. Heyneman CW, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60:555-574. Notman R, Noro M, O’Malley B, Anwar J. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. J Am Chem Soc. 2006;128:13982-13983. PENNSAID [package insert]. Mississauga, Ontario:Nuvo Research, Inc.; 2010.

INDICATION
PENNSAID® is a nonsteroidal anti-inflammatory drug (NSAID) used for treating the signs and symptoms of osteoarthritis of the knee(s).

IMPORTANT RISK INFORMATION

WARNING: CARDIOVASCULAR (CV) AND GASTROINTESTINAL (GI) RISK
    Cardiovascular Risk
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of serious blood clots in the heart, or cause a heart attack or stroke. These risks can cause death. The risk may increase the longer NSAIDs are used. Patients who have heart disease or are at risk for heart disease may be at greater risk
  • Do not use PENNSAID in patients who are in the hospital for heart bypass surgery grafts
    Gastrointestinal Risk
  • NSAIDs cause an increased risk of serious stomach problems or problems in the intestines. Patients could bleed or develop a hole in their stomach or intestines. All of these problems can cause death. These problems can happen at any time with no warning when using NSAIDs. Older patients are at greater risk for these problems

COVIDIEN, COVIDIEN with logo and Covidien logo are U.S. and internationally registered trademarks of Covidien AG.
PENNSAID is a registered trademark of Nuvo Research Inc. Other brands are trademarks of their respective owners. © 2011 Covidien